L. Hazan's Profile

Role	Title	Level	Year	L/R
🐜	A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial 141 auth. A. Blauvelt, K. Papp, A. Gottlieb, A. Jarell, K. Reich, C. Maari, K. Gordon, L. Ferris, R. Langley, Y. Tada, R. Lima, H. Elmaraghy, G. Gallo, L. Renda, S.Y. Park, ... R. Burge, J. Bagel, R. Vender, M. Lomaga, I. Delorme, C. Hong, Richard Langley, L. Albrecht, L. Guenther, C. Maari, K. Papp, Kamal K. Singh Ohson, K. Barber, C. Lynde, Aditya K. Gupta, L. Rosoph, Jean-Sébastien Gauthier, M. Gooderham, N. Wasel, M. Raman, M. Wiseman, David Greenstein, A. Jarell, Charles Moon, Lani Clark, Sadra Jazayeri, M. Bukhalo, A. Moore, T. Hamilton, A. Gewirtzman, L. Hazan, J. Crowley, C. Teller, M. Zirwas, Stacy Smith, M. Christine Lee, S. Tyring, P. Lee, S. Dhawan, C. Leonardi, Amarilis Perez‐De Jesus, Wendy L McFalda, E. Frankel, P. Yamauchi, S. Fretzin, Rocco Serrao, T. Schlesinger, S. Gottlieb, P. Jenkin, Rola Gharib, Steven Davis, Navid Nami, Z. Draelos, Lloyd Godwin, Cindy Owen, M. Landis, W. Abramovits, Samuel Sanchez-Rivera, A. V. Van Voorhees, David Fivenson, F. Kerdel, S. Forman, Jeffrey Weinberg, José González-Chávez, B. Boyce, L. Stein-Gold, Charles P Hudson, Constance M. Brown, James Coggi, C. Feser, R. Forconi, S. Johnson, M. McCune, L. Green, V. Madkan, D. M. Shipp, K. Gordon, J. Waibel, O. Soto-Raices, J. Cather, Scott Miller, J. Scott, Douglas Young, J. Kaffenberger, Kelley Yokum, M. Zook, A. Blauvelt, A. Truett, G. Schmieder, G. Mccracken, P. McElgunn, J. Herrmann, J. M. Suchniak, J. Appel, E. Barranco, Mark Lee, J. Bagel, Lawrence Osman, A. Cauthen, N. Sadick, Eneida De La Torre, Kelly N. Taylor, David Cohen, H. Harris, J. Soung, Vassilios A Dimitropoulos, Stephen Miller, C. Barnes, Rawan Jumean‐Haddad, S. Bruce, Lawrence Cheung, S. Guenthner, A. Gaspari, V. Laquer, J. Krell, Shahram Jacobs, W. Nahm, N. Korman, B. Elewski, L. Ferris, K. Duffin, D. Pariser, Brianna E. Johnson, P. Wallace, Jeffrey B. Travers, R. Fried	6	2019	6 🐜
🐜	Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children? 15 auth. Jennifer S. Li, Katherine Y. Berezny, R. Kilaru, L. Hazan, R. Portman, R. Hogg, R. Jenkins, P. Kanani, C. Cottrill, T. Mattoo, ... L. Zharkova, L. Kozlova, Irit Weisman, D. Deitchman, R. Califf	6	2004	6 🐜
🦁	A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension L. Hazan, Oscar A. Hernández Rodriguez, As'ad E. Bhorat, K. Miyazaki, B. Tao, R. Heyrman	5	2010	5 🦁
🐜	Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. 16 auth. S. Morris, C. Bristow, Michael R. Wierzbicki, M. Sarno, L. Asbel, A. French, C. Gaydos, L. Hazan, L. Mena, P. Madhivanan, ... S. Philip, Saara Schwartz, Constance A. Brown, D. Styers, Toni Waymer, J. Klausner	5	2020	5 🐜
🐜	Racial differences are seen in blood pressure response to fosinopril in hypertensive children. 11 auth. S. Menon, Katherine Y. Berezny, R. Kilaru, D. Benjamin, J. Kay, L. Hazan, ... R. Portman, R. Hogg, D. Deitchman, R. Califf, Jennifer S. Li	4	2006	4 🐜
🐬	Efficacy and Safety of Honey Bee Venom (Apis mellifera) Dermal Injections to Treat Osteoarthritis Knee Pain and Physical Disability: A Randomized Controlled Trial. Vicki J Conrad, L. Hazan, Agustin J Latorre, A. Jakubowska, Christopher M. H. Kim	4	2019	4 🐬
🐜	Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation 9 auth. V. Bowles, Lisa Jenkins VanLuvanee, Hugh Alsop, L. Hazan, K. Shepherd, Srinivas Sidgiddi, ... K. Allenby, Tiina Ahveninen, Sharon Hanegraaf	4	2018	4 🐜
🦁	Pharmacokinetics and Safety of 0.5% Ivermectin Lotion for Head Louse Infestations L. Hazan, J. E. Berg, J. Bowman, J. Murray, W. G. Ryan	3	2013	3 🦁